Long-term tumor-free survival from treatment with the GFP–TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

Nam W. Kim, Mieczyslaw A. Piatyszek, Karen R. Prowse et al. · Science · 1994 · 7.1K citations

Life Sciences, Cell Biology, Oncology +16

Cancer statistics, 1996

T. Tong, S. Bolden, Phyllis A. Wingo · CA A Cancer Journal for Clinicians · 1996 · 1.8K citations · Full text

Medicine, Biostatistics, Oncology +17

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

Mark N. Levine, V. Bramwell, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 1998 · 623 citations

Medicine, Oncology, Pharmacotherapy +10

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

Maccon Keane, Seth A. Ettenberg, Marion M. Nau et al. · PubMed · 1999 · 557 citations

Life Sciences, Oncology, Pharmacology +17

Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.

Jian Gu, Shunsuke Kagawa, Masahiro Takakura et al. · PubMed · 2000 · 187 citations

Life Sciences, Molecular Biology, Oncology +13